GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Gross-Profit-to-Asset %

ASKA Pharmaceutical Holdings Co (TSE:4886) Gross-Profit-to-Asset % : 36.17% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ASKA Pharmaceutical Holdings Co's annualized Gross Profit for the quarter that ended in Dec. 2023 was 円33,780 Mil. ASKA Pharmaceutical Holdings Co's average Total Assets over the quarter that ended in Dec. 2023 was 円93,389 Mil. Therefore, ASKA Pharmaceutical Holdings Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 36.17%.


ASKA Pharmaceutical Holdings Co Gross-Profit-to-Asset % Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Gross-Profit-to-Asset % Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
31.63 33.54 34.48

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.96 33.86 34.12 36.17 30.31

Competitive Comparison of ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset % falls into.



ASKA Pharmaceutical Holdings Co Gross-Profit-to-Asset % Calculation

ASKA Pharmaceutical Holdings Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=30664/( (87138+90745)/ 2 )
=30664/88941.5
=34.48 %

ASKA Pharmaceutical Holdings Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=33780/( (91920+94857)/ 2 )
=33780/93388.5
=36.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


ASKA Pharmaceutical Holdings Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Traded in Other Exchanges
N/A
Address
2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines